Canadian Expert Group consensus recommendations: KRAS testing in colorectal cancer

Monoclonal antibodies against the epidermal growth factor receptor (anti-egfr) when used in the treatment of metastatic colorectal cancer are associated with improved survival. Patients whose tumours harbor a KRAS mutation in codon 12 or 13 have been shown not to benefit from anti-egfr antibodies. T...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Aubin, F., Gill, S., Burkes, R., Colwell, B., Kamel–Reid, S., Koski, S., Pollett, A., Samson, B., Tehfe, M., Wong, R., Young, S., Soulières, D.
Format: Artigo
Idioma:Inglês
Publicat: Multimed Inc. 2011
Matèries:
Medical Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3149550/
https://ncbi.nlm.nih.gov/pubmed/21874108
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars